Categories
| Category | |
|---|---|
| Pharmacy | 40% |
| Health Conditions and Concerns | 20% |
| Health | 20% |
| Others | 20% |
Explore sites in same category:
- qelbree.com Rank 1.2M. Estimated value 1,800$
- muramed.com Rank 2M. Estimated value 1,080$
- sunovionprofile.com Rank 1.4M. Estimated value 1,500$
- pillsync.com Rank 1.3M. Estimated value 1,620$
- rocketrx.com Rank 759K. Estimated value 2,844$
- mounjaro.com Rank 153.7K. Estimated value 14,208$
- paxlovid.com Rank 139.7K. Estimated value 15,648$
- jsnp.org Rank 2.7M. Estimated value 792$
- dpdcir.com Rank 181.5K. Estimated value 12,012$
- rapidtestandtrace.ca Rank 2.2M. Estimated value 996$
Keyword Suggestion
Domain Informations
Sotyktu.com lookup results from whois.corporatedomains.com server:
- Domain created: 2021-05-13T16:24:29Z
- Domain updated: 2024-05-09T05:07:47Z
- Domain expires: 2025-05-13T16:24:29Z 0 Years, 320 Days left
- Website age: 3 Years, 44 Days
- Registrar Domain ID: 2611874099_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- NS1.BMS.COM
- NS2.BMS.COM
- NS3.BMS.COM
- NS4.BMS.COM
Network
- inetnum : 45.60.0.0 - 45.60.255.255
- name : INCAPSULA-NET
- handle : NET-45-60-0-0-1
- status : Direct Allocation
- created : 2010-09-15
- changed : 2023-02-27
Owner
- organization : Incapsula Inc
- handle : INCAP-5
- address : Array,Redwood Shores,CA,94065,US
Technical support
- handle : IMPER9-ARIN
- name : Imperva
- phone : +1-450-405-4945
- email : [email protected]
Abuse
- handle : IMPER7-ARIN
- name : Imperva AbuseDesk
- phone : +1-866-250-7659
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 45.60.150.161
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 45.60.150.161)
Spam Check (IP: 45.60.150.161)
Websites Listing
We found Websites Listing below when search with sotyktu.com on Search Engine
Home [sotyktu.ca]
Web Welcome to the SOTYKTU TM Resource Centre This website is intended to provide educational materials and information about SOTYKTU to Canadian healthcare …
Sotyktu.caHealth Canada Has Approved (Pr)SOTYKTU™ …
Web Nov 28, 2022 · SOTYKTU is a tyrosine kinase 2 (TYK2) inhibitor, which works by selectively blocking the activity of the "TYK2" enzyme, which is involved in the process of …
Newswire.caSOTYKTU™ (deucravacitinib) for Moderate-to-Severe Plaque …
Web Infections: SOTYKTU may increase the risk of infections. Serious infections have been reported in patients with psoriasis who received SOTYKTU. The most common serious …
Sotyktuhcp.comSotyktu (deucravacitinib
Web Sotyktu contiene el principio activo deucravacitinib. ¿Cómo se usa Sotyktu? Sotyktu solo se podrá dispensar con receta médica. El tratamiento debe iniciarlo un médico con …
Ema.europa.euSOTYKTU U.S. Prescribing Information
Web SOTYKTU may increase the risk of infection. Avoid use in patients with active or serious infection. If a serious infection develops, discontinue SOTYKTU until the infection …
Packageinserts.bms.comStyleTuck - Facebook
Web Sep 5, 2017 · StyleTuck. 501 likes. The StyleTuck woman has a unique style and does not compare to anyone else. She creates her style for herself and is remembered...
Facebook.comSotyktu | Medikamente
Web 2 days ago · flashws. Macht denn evtl. jemand schon seine Erfahrungen mit Sotyktu und könnte berichten?? Erfahrungen austauschen über das Leben mit Schuppenflechte, …
Psoriasis-netz.de逃离JAK抑制剂“连坐”：BMS与辉瑞的两种思路_Sotyktu_安全性_疗效
Web Apr 8, 2023 · 虽然相比生物制剂的疗效，Sotyktu仍有一定差距，但口服剂性带来与众不同的差异化竞争优势。 武田制药、Ventyx等宣扬自己的变构抑制剂比Sotyktu更优。 如果根 …
Sohu.comSotyktu（deucravacitinib）获欧盟批准用于治疗斑块状银屑病，效 …
Web Apr 6, 2023 · 斑块状银屑病治疗药物Sotyktu（deucravacitinib）已获得欧盟委员会（EC）的批准，适用于适合全身治疗的中度至重度病例的成人。. 根Sotyktu成为欧盟第一个用于 …
Headkonmed.com德卡伐替尼Sotyktu (deucravacitinib) 是什么药-药纷享进口药
Web 德卡伐替尼Sotyktu (deucravacitinib) 是什么药. 德卡伐替尼于2022年9月首次获得美国FDA批准，用于治疗中重度斑块型银屑病。. 后来在2022年11月被加拿大卫生部批准。. 德卡伐 …
Xinyaozx.com每日一次口服治疗，Sotyktu于欧盟获批治疗成人银屑病 - 知乎
Web Mar 29, 2023 · 每日一次口服治疗，Sotyktu于欧盟获批治疗成人银屑病. 3月29日， 百时美施贵宝 （BMS）公司宣布，欧盟委员会批准了其自研药物 Sotyktu （deucravacitinib）用 …
Zhuanlan.zhihu.com德卡伐替尼/氘可来昔替尼(Sotyktu)治疗斑块性银屑病疗效优于阿普 …
Web Apr 13, 2023 · 作为首款TYK2抑制剂，德卡伐替尼的临床疗效已证明优于阿普米司特，并且无JAK抑制剂相关安全性风险。. 研究结果证实了在以中国患者为主的亚洲中重度斑块状 …
Kangbixing.com斑块型银屑病口服疗法Sotyktu (deucravacitinib)获欧盟批准-上市
Web Apr 7, 2023 · 香港济民药业提供Sotyktu (deucravacitinib)上市时间，在哪买，价格，最新临床研究进展，副作用，适应症，国内上市购买，医保信息等Sotyktu (deucravacitinib)的 …
Pidrug.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| targetedcashnow.com | pananames.com | -1 Years, -354 Days |
| purwell.com | godaddy.com | 71 Days |
| nimblrschool.com | godaddy.com | -1 Years, -263 Days |
| maxima.com | godaddy.com | 3 Years, 191 Days |
| dillonlawgp.com | cloudflare.com | -2 Years, -74 Days |
| digirati.com | registrar.amazon.com | -1 Years, -213 Days |
| koala-arms.com | namesilo.com | -2 Years, -36 Days |
| blnovels.net | publicdomainregistry.com | -1 Years, -230 Days |
| ybx8.com | namesilo.com | -1 Years, -288 Days |
| nccig.ca | ca.godaddy.com | 2 Years, 201 Days |